Compounds > n-methyl-3,4-methylenedioxyamphetamine

n-methyl-3,4-methylenedioxyamphetamine and sb 3ct compound

n-methyl-3,4-methylenedioxyamphetamine has been researched along with sb 3ct compound in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colado, MI; Fernández-Valle, ME; Gutiérrez-López, MD; O'Shea, E; Pérez-Hernández, M; Rubio-Araiz, A; Vidal, R	1

Other Studies

1 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and sb 3ct compound

Article	Year
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus. Neuropharmacology, 2017, 05-15, Volume: 118 Topics: Animals; Aquaporin 4; Blood-Brain Barrier; Brain Edema; Claudin-5; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hallucinogens; Heterocyclic Compounds, 1-Ring; Low Density Lipoprotein Receptor-Related Protein-1; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 9; N-Methyl-3,4-methylenedioxyamphetamine; Permeability; Plasminogen; Rats; Sulfones; Time Factors	2017

Article

Year

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus.

Neuropharmacology, 2017, 05-15, Volume: 118

Topics: Animals; Aquaporin 4; Blood-Brain Barrier; Brain Edema; Claudin-5; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hallucinogens; Heterocyclic Compounds, 1-Ring; Low Density Lipoprotein Receptor-Related Protein-1; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 9; N-Methyl-3,4-methylenedioxyamphetamine; Permeability; Plasminogen; Rats; Sulfones; Time Factors

2017